Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines Export

@article{citeulike:2924135, abstract = {Standardized criteria for diagnosis and response assessment are needed to interpret and compare clinical trials and for approval of new therapeutic agents by regulatory agencies. Therefore, a National Cancer Institute-sponsored Working Group (NCI-WG) on chronic lymphocytic leukemia (CLL) published guidelines for the design and conduct of clinical trials for patients with CLL in 1988, which were updated in 1996. During the past decade, considerable progress has been achieved in defining new prognostic markers, diagnostic parameters, and treatment options. This prompted the International Workshop on Chronic Lymphocytic Leukemia (IWCLL) to provide updated recommendations for the management of CLL in clinical trials and general practice. 10.1182/blood-2007-06-093906}, author = {Hallek, Michael and Cheson, Bruce D. and Catovsky, Daniel and Caligaris-Cappio, Federico and Dighiero, Guillaume and Dohner, Hartmut and Hillmen, Peter and Keating, Michael J. and Montserrat, Emili and Rai, Kanti R. and Kipps, Thomas J.}, citeulike-article-id = {2924135}, citeulike-linkout-0 = {http://dx.doi.org/10.1182/blood-2007-06-093906}, citeulike-linkout-1 = {http://bloodjournal.hematologylibrary.org/cgi/content/abstract/111/12/5446}, citeulike-linkout-2 = {http://view.ncbi.nlm.nih.gov/pubmed/18216293}, citeulike-linkout-3 = {http://www.hubmed.org/display.cgi?uids=18216293}, day = {15}, doi = {10.1182/blood-2007-06-093906}, journal = {Blood}, keywords = {cll}, month = {June}, number = {12}, pages = {5446--5456}, posted-at = {2008-07-29 01:38:53}, priority = {2}, title = {Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines}, url = {http://dx.doi.org/10.1182/blood-2007-06-093906}, volume = {111}, year = {2008} }

TY - JOUR ID - citeulike:2924135 L3 - citeulike-article-id:2924135 N2 - Standardized criteria for diagnosis and response assessment are needed to interpret and compare clinical trials and for approval of new therapeutic agents by regulatory agencies. Therefore, a National Cancer Institute-sponsored Working Group (NCI-WG) on chronic lymphocytic leukemia (CLL) published guidelines for the design and conduct of clinical trials for patients with CLL in 1988, which were updated in 1996. During the past decade, considerable progress has been achieved in defining new prognostic markers, diagnostic parameters, and treatment options. This prompted the International Workshop on Chronic Lymphocytic Leukemia (IWCLL) to provide updated recommendations for the management of CLL in clinical trials and general practice. 10.1182/blood-2007-06-093906 IS - 12 JF - Blood EP - 5456 TI - Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines VL - 111 SP - 5446 KW - cll AU - Hallek, Michael AU - Cheson, Bruce AU - Catovsky, Daniel AU - Caligaris-Cappio, Federico AU - Dighiero, Guillaume AU - Dohner, Hartmut AU - Hillmen, Peter AU - Keating, Michael AU - Montserrat, Emili AU - Rai, Kanti AU - Kipps, Thomas PY - 2008/06/15/ UR - http://dx.doi.org/10.1182/blood-2007-06-093906 ER -